ARSUF
Price
$20.03
Change
-$0.82 (-3.93%)
Updated
Oct 29 closing price
Capitalization
1.79B
BOIRF
Price
$24.50
Change
+$0.20 (+0.82%)
Updated
Aug 29 closing price
Capitalization
464.45M
Interact to see
Advertisement

ARSUF vs BOIRF

Header iconARSUF vs BOIRF Comparison
Open Charts ARSUF vs BOIRFBanner chart's image
Fagron SA
Price$20.03
Change-$0.82 (-3.93%)
Volume$425
Capitalization1.79B
Boiron
Price$24.50
Change+$0.20 (+0.82%)
Volume$800
Capitalization464.45M
ARSUF vs BOIRF Comparison Chart in %
Loading...
ARSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BOIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARSUF vs. BOIRF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARSUF is a Hold and BOIRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (ARSUF: $20.03 vs. BOIRF: $24.50)
Brand notoriety: ARSUF and BOIRF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ARSUF: 100% vs. BOIRF: 271%
Market capitalization -- ARSUF: $1.79B vs. BOIRF: $464.45M
ARSUF [@Pharmaceuticals: Generic] is valued at $1.79B. BOIRF’s [@Pharmaceuticals: Generic] market capitalization is $464.45M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARSUF’s FA Score shows that 1 FA rating(s) are green whileBOIRF’s FA Score has 2 green FA rating(s).

  • ARSUF’s FA Score: 1 green, 4 red.
  • BOIRF’s FA Score: 2 green, 3 red.
According to our system of comparison, both ARSUF and BOIRF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARSUF’s TA Score shows that 1 TA indicator(s) are bullish while BOIRF’s TA Score has 2 bullish TA indicator(s).

  • ARSUF’s TA Score: 1 bullish, 0 bearish.
  • BOIRF’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, ARSUF is a better buy in the short-term than BOIRF.

Price Growth

ARSUF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while BOIRF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARSUF($1.79B) has a higher market cap than BOIRF($464M). BOIRF has higher P/E ratio than ARSUF: BOIRF (32.33) vs ARSUF (17.97). ARSUF YTD gains are higher at: 0.000 vs. BOIRF (-14.035).
ARSUFBOIRFARSUF / BOIRF
Capitalization1.79B464M386%
EBITDA171MN/A-
Gain YTD0.000-14.035-
P/E Ratio17.9732.3356%
Revenue919MN/A-
Total Cash89.3MN/A-
Total Debt403MN/A-
FUNDAMENTALS RATINGS
ARSUF vs BOIRF: Fundamental Ratings
ARSUF
BOIRF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
7
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5470
PRICE GROWTH RATING
1..100
7364
P/E GROWTH RATING
1..100
489
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BOIRF's Valuation (7) in the null industry is in the same range as ARSUF (25). This means that BOIRF’s stock grew similarly to ARSUF’s over the last 12 months.

BOIRF's Profit vs Risk Rating (100) in the null industry is in the same range as ARSUF (100). This means that BOIRF’s stock grew similarly to ARSUF’s over the last 12 months.

ARSUF's SMR Rating (54) in the null industry is in the same range as BOIRF (70). This means that ARSUF’s stock grew similarly to BOIRF’s over the last 12 months.

BOIRF's Price Growth Rating (64) in the null industry is in the same range as ARSUF (73). This means that BOIRF’s stock grew similarly to ARSUF’s over the last 12 months.

BOIRF's P/E Growth Rating (9) in the null industry is somewhat better than the same rating for ARSUF (48). This means that BOIRF’s stock grew somewhat faster than ARSUF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARSUFBOIRF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 3 days ago
38%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
18%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
13%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
19%
Bullish Trend 3 days ago
10%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
19%
Bearish Trend 3 days ago
32%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ARSUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BOIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APDDX23.390.40
+1.74%
Artisan Global Discovery Advisor
NOMIX22.070.11
+0.50%
Northern Mid Cap Index
PEIIX42.970.04
+0.09%
Principal Equity Income Inst
SAOIX30.52-0.14
-0.46%
NAA Opportunity Institutional
WPSIX56.23-0.61
-1.07%
AB Concentrated Growth I

ARSUF and

Correlation & Price change

A.I.dvisor tells us that ARSUF and GENPF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARSUF and GENPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARSUF
1D Price
Change %
ARSUF100%
N/A
GENPF - ARSUF
23%
Poorly correlated
N/A
AVCNF - ARSUF
11%
Poorly correlated
+0.48%
BOIRF - ARSUF
1%
Poorly correlated
N/A
BIOVF - ARSUF
1%
Poorly correlated
N/A
ABSCF - ARSUF
0%
Poorly correlated
N/A
More

BOIRF and

Correlation & Price change

A.I.dvisor tells us that BOIRF and ELAN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOIRF and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOIRF
1D Price
Change %
BOIRF100%
N/A
ELAN - BOIRF
24%
Poorly correlated
+5.50%
BUDZ - BOIRF
7%
Poorly correlated
+0.90%
BIOVF - BOIRF
1%
Poorly correlated
N/A
ARSUF - BOIRF
1%
Poorly correlated
N/A
CAIHF - BOIRF
0%
Poorly correlated
N/A
More